GILD · News · 20260919N
Revenue Performance and Mix
GILEAD SCIENCES, INC. · 2026-09-19 · Importance 47 · Surprise 22 · No source text
Gilead Sciences reported latest-quarter revenue of $7.80 billion. Revenue increased 10.6% year over year, exceeding the materiality threshold for mandatory inclusion. Latest quarterly earnings surpassed analysts’ expectations, although the report provided no segment or sequential revenue breakdown.
Key facts
- Gilead's revenue in the latest quarter increased by 10.6% year-over-year to $7.80 billion. source
- Gilead's latest quarterly earnings surpassed expectations. source
- Analysts' consensus for Gilead Sciences is "Moderate Buy" with an average price target of $158.78. source
- Wall Street Zen has upgraded Gilead Sciences (NASDAQ:GILD) to a "buy" rating from "hold". source
- Gilead's stock opened near its 12-month high on the publication day. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +9.6% | Gilead's revenue in the latest quarter increased by 10.6% year-over-year to $7.80 billion. |